PloS one

journal of immunology research

BioMed research international

colloids and surfaces b, biointerfaces

Plants (Basel, Switzerland)

Clinical oral investigations

future microbiology

Frontiers in cellular and infection microbiology

Archives of oral biology

journal of materials chemistry b

cell chemical biology

Infection and immunity

[1] In Vitro and In Vivo Anti- spp. Activity of Plant-Derived Products.

[2] Antifungal activity and Shore A hardness of a tissue conditioner incorporated with terpinen-4-ol and cinnamaldehyde.

[3] Effect of chitosan nanoparticles on the inhibition of Candida spp. biofilm on denture base surface.

[4] Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp.

[5] Effect of Strength Training on Oxidative Stress and the Correlation of the Same with Forearm Vasodilatation and Blood Pressure of Hypertensive Elderly Women: A Randomized Clinical Trial.

[6] Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis.

[7] Expression pattern of transcription factors and intracellular cytokines reveals that clinically cured tuberculosis is accompanied by an increase in Mycobacterium-specific Th1, Th2, and Th17 cells.

[8] Overcoming Fungal Echinocandin Resistance through Inhibition of the Non-essential Stress Kinase Yck2.

[9] Face/Off: The Interchangeable Side of .

[10] Novel nanocarrier of miconazole based on chitosan-coated iron oxide nanoparticles as a nanotherapy to fight Candida biofilms.

[11] Assembly and antifungal effect of a new fluconazole-carrier nanosystem.

[12] A T/T dual functional iron oxide MRI contrast agent with super stability and low hypersensitivity benefited by ultrahigh carboxyl group density.

[13] candida–epithelial interactions

[14] fungemia caused by candida species in a children's public hospital in the city of sÃo paulo, brazil: study in the period 2007-2010

[15] comparación de métodos de microdilución clsi m27-a2 y eucast en aislamientos de candida spp. en pacientes con cáncer clsi microdilution m27-a2 and eucast method comparison for candida spp. in patients with cancer

[16] candida colonization and species identification by two methods in nicu newborn

[17] burden and treatment patterns of invasive fungal infections in hospitalized patients in the middle east: real-world data from saudi arabia and lebanon

[18] fluconazole susceptibility of 3,056 clinical isolates of candida species from 2005 to 2009 in a tertiary-care hospital

[19] oropharyngeal candidosis in hiv-infected patients—an update

[20] neutrophil integrins and matrix ligands and net release

[21] prevalence of bacterial and fungal agents causing lower respiratory tract infections in patients with human immunodeficiency virus infection

[22] molecular characterization of candida spp. isolates from patients with bloodstream infections

[23] immunobiological activity of synthetically prepared immunodominant galactomannosides structurally mimicking aspergillus galactomannan

[24] freqüência de onicomicoses por leveduras em maringá, paraná, brasil frequency of onychomycoses caused by yeasts in maringa, parana, brazil

[25] lactobacillus fermentum atcc 23271 displays in vitro inhibitory activities against candida spp.

[26] use of the vitek 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species

[27] proper sterol distribution is required for candida albicans hyphal formation and virulence

[28] the use of natural assets of reeds marshland in vojvodina in view of sustainable development

[29] the role of antifungals against candida biofilm in catheter-related candidemia

[30] host pathogen relations: exploring animal models for fungal pathogens

[31] treatment with some anti-inflammatory drugs reduces germ tube formation in candida albicans strains

[32] adherence to hela cells, typing by killer toxins and susceptibility to antifungal agents of candida dubliniensis strains adesão a células hela, tipagem pelas toxinas "killer" e sensibilidade a antifúngicos de cepas de candida dubliniensis

[33] Pseudomonas Synergizes with Fluconazole against during Treatment of Polymicrobial Infection.

[34] Clinical candidates modulating protein-protein interactions: The fragment-based experience.

[35] Identification of Candidate Ergosterol-Responsive Proteins Associated with the Plasma Membrane of .

[36] Antimicrobial effects of microwave-induced plasma torch (MiniMIP) treatment on Candida albicans biofilms.

[37] Diversity-oriented synthesis of pyrazoles derivatives from flavones and isoflavones leads to the discovery of promising reversal agents of fluconazole resistance in Candida albicans

[38] Synthesis, in Vitro Evaluation, and Radiolabeling of Fluorinated Puromycin Analogues: Potential Candidates for PET Imaging of Protein Synthesis.

[39] A Network of Paralogous Stress Response Transcription Factors in the Human Pathogen Candida glabrata.

[40] Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: Case report and review of the literature.

[41] Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.

[42] Rapid hepatic clearance of 99mTc-TMEOP: a new candidate for myocardial perfusion imaging.

[43] Rapid susceptibility testing and microcolony analysis of Candida spp. cultured and imaged on porous aluminum oxide.

[44] In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species.

[45] An Unexpected Degradation Pathway of a 1,2,4-Triazolo[4,3-a]pyridine Derivative: The Formation of 2 Cationic Pseudodimers of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Drug Candidate in a Stressed Capsule Formulation.

[46] Modeling molecular interactions of propounded pyrazole based drug candidates against bacterial DNA gyrase: Validation by syntheses and biological studies

[47] Inhibition activity prediction for a dataset of candidates' drug by combining fuzzy logic with MLR/ANN QSAR models.

[48] In Vitro Interaction of Geldanamycin with Triazoles and Echinocandins Against Common and Emerging Candida Species.

[49] The efflux pump inhibitor tetrandrine exhibits synergism with fluconazole or voriconazole against Candida parapsilosis.

[50] Management of candidaemia with reference to the European confederation of medical mycology quality indicators

[51] Effects of Several Common Antifungal Drugs (Clotrimazole, Miconazole, Fluconazole) alone and in Combination with Amphotericin B on Candida Species Isolated from Chronic Candidal Vulvovaginitis

[52] Primary School Teachers and Teacher Candidates' Perceptions of Efficiency in Designing and Implementing Teaching Based on Individual Differences

[53] Prevalence of Candida blood stream infections among children in tertiary care hospital: detection of species and antifungal susceptibility

[54] Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis

[55] Candida isolates causing refractory or recurrent oropharyngeal candidiasis in 11 hospitals in China

[56] Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells

[57] Mechanisms of azole resistance in clinical isolates of Candida glabrata from two hospitals in China

[58] Resistance rates of non-albicans Candida infections in Taiwan after the revision of 2012 Clinical and Laboratory Standards Institute breakpoints

[59] A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections

[60] Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility

[61] Efficiency of gold nanoparticles coated with the antimicrobial peptide indolicidin against biofilm formation and development of Candida spp. clinical isolates

[62] Epidemiology, practice patterns, and prognostic factors for candidemia; and characteristics of fourteen patients with breakthrough Candida bloodstream infections: a single tertiary hospital experience in Japan

[63] Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar

[64] Clinical characteristics of the first cases of invasive candidiasis in China due to pan-echinocandin-resistant Candida tropicalis and Candida glabrata isolates with delineation of their resistance mechanisms

[65] Fluconazole resistance in Candida species: a current perspective

[66] Current perspective on emergence, diagnosis and drug resistance in Candida auris

[67] Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients

[68] Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience

[69] A necrotic lung ball caused by co-infection with Candida and Streptococcus pneumoniae

[70] Anidulafungin and its role in candida infections

[71] Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

[72] Prevalence of Candida blood stream infections among children in tertiary care hospital: detection of species and antifungal susceptibility

[73] Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis

[74] Prevalence of Candida blood stream infections among children in tertiary care hospital: detection of species and antifungal susceptibility

[75] Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis

[76] Candida isolates causing refractory or recurrent oropharyngeal candidiasis in 11 hospitals in China

[77] Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells

[78] Mechanisms of azole resistance in clinical isolates of Candida glabrata from two hospitals in China

[79] Resistance rates of non-albicans Candida infections in Taiwan after the revision of 2012 Clinical and Laboratory Standards Institute breakpoints

[80] A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections

[81] Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility

[82] Efficiency of gold nanoparticles coated with the antimicrobial peptide indolicidin against biofilm formation and development of Candida spp. clinical isolates

[83] Epidemiology, practice patterns, and prognostic factors for candidemia; and characteristics of fourteen patients with breakthrough Candida bloodstream infections: a single tertiary hospital experience in Japan

[84] Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar

[85] Clinical characteristics of the first cases of invasive candidiasis in China due to pan-echinocandin-resistant Candida tropicalis and Candida glabrata isolates with delineation of their resistance mechanisms

[86] Fluconazole resistance in Candida species: a current perspective

[87] Current perspective on emergence, diagnosis and drug resistance in Candida auris

[88] Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients

[89] Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience

[90] A necrotic lung ball caused by co-infection with Candida and Streptococcus pneumoniae

[91] Anidulafungin and its role in candida infections

[92] Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

[93] Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania

[94] Primary School Teachers and Teacher Candidates' Perceptions of Efficiency in Designing and Implementing Teaching Based on Individual Differences

[95] Integrating genome-wide association study and methylation functional annotation data identified candidate genes and pathways for schizophrenia.

[96] Potential candidates for biological control of the black bean aphid Aphis fabae in Serbia

[97] NIR-Cyanine Dye Linker: a Promising Candidate for Isochronic Fluorescence Imaging in Molecular Cancer Diagnostics and Therapy Monitoring.

[98] Health Literacy, Health Numeracy, and Cognitive Functioning Among Bariatric Surgery Candidates.

[99] Physiological responses of Broussonetia papyrifera to manganese stress, a candidate plant for phytoremediation

[100] Underlying Differences in Health Spending Within the World Health Organisation Europe Region-Comparing EU15, EU Post-2004, CIS, EU Candidate, and CARINFONET Countries.

[101] enome Assembly and Comparative Genomics of the Barley Leaf Rust Pathogen Identifies Candidates for Three Avirulence Genes.